Private Trust Company’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.6K Buy
496
+195
+65% +$40.3K 0.01% 1038
2025
Q4
$62.2K Buy
301
+224
+291% +$44.8K 0.01% 1206
2025
Q3
$13.8K Buy
77
+28
+57% +$4.77K ﹤0.01% 1785
2025
Q2
$7.91K Sell
49
-35
-42% -$5.58K ﹤0.01% 1889
2025
Q1
$14.3K Buy
84
+35
+71% +$6.08K ﹤0.01% 1681
2024
Q4
$8.14K Sell
49
-71
-59% -$12.1K ﹤0.01% 1815
2024
Q3
$20.6K Sell
120
-317
-73% -$52.5K ﹤0.01% 1463
2024
Q2
$67.3K Buy
437
+15
+4% +$2.25K 0.01% 1008
2024
Q1
$64.9K Sell
422
-77
-15% -$11.7K 0.01% 1012
2023
Q4
$78.9K Hold
499
0.01% 902
2023
Q3
$73K Hold
499
0.01% 900
2023
Q2
$76.4K Hold
499
0.01% 893
2023
Q1
$77.4K Buy
499
+310
+164% +$48.7K 0.01% 858
2022
Q4
$29K Sell
189
-30
-14% -$4.43K ﹤0.01% 1161
2022
Q3
$29K Sell
219
-129
-37% -$18.1K ﹤0.01% 1078
2022
Q2
$47K Buy
+348
New +$48K 0.01% 947

Other funds holding FBT

Private Trust Company's FBT Position: Q1 2026 in Review

Private Trust Company increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 65% in Q1 2026, buying an estimated $40.3K and bringing the position to 496 shares worth $99.6K. The position accounts for 0.01% of the portfolio, ranked #1038.

Private Trust Company first reported a position in FBT in Q2 2022 and has held it in 16 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Private Trust Company held 496 shares of First Trust NYSE Arca Biotechnology Index Fund worth $99.6K as of Q1 2026.
  • Private Trust Company bought 195 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $40.3K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Private Trust Company's portfolio in Q1 2026, its #1038 holding.
  • Private Trust Company first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2022 and has held it in 16 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.